Tonix Pharmaceuticals Holding (TNXP) Other Non-Current Assets (2010 - 2026)

Tonix Pharmaceuticals Holding's (TNXP) quarterly Other Non-Current Assets came in at $5000.0 in Q1 2026, down 99.44% year-on-year from $900000.0 in Q1 2025, and little changed quarter-over-quarter from $5000.0 in Q4 2025.

Tonix Pharmaceuticals Holding (TNXP) Other Non-Current Assets (2010 - 2026) Analysis & Trends

Tonix Pharmaceuticals Holding's Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $5000.0 for Q1 2026.

  • On a quarterly basis, Other Non-Current Assets fell 99.44% year-over-year to $5000.0 in Q1 2026; TTM through Mar 2026 was $5000.0, a 99.44% decrease from a year earlier, with the FY2025 full-year figure at $5000.0, down 99.47% from the prior year.
  • Other Non-Current Assets was little changed at $5000.0 in Q1 2026 per TNXP's latest filing, from $5000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $1.3 million in Q3 2025 and bottomed at $5000.0 in Q4 2025.
  • The 5-year median for Other Non-Current Assets is $900000.0 (2025), against an average of $658941.2.
  • Across the five-year window, Other Non-Current Assets jumped 327.65% in 2023 and slumped 99.47% in 2025, its largest moves.
  • Year by year, Other Non-Current Assets stood at $264000.0 in 2022, then soared by 327.65% to $1.1 million in 2023, then declined by 15.77% to $951000.0 in 2024, then slumped by 99.47% to $5000.0 in 2025, then changed by 0.0% to $5000.0 in 2026.
  • Per Business Quant, the three latest TNXP Other Non-Current Assets figures stand at $5000.0 (Q1 2026), $5000.0 (Q4 2025), and $1.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 1.02 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 60,000.00
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 104.24 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - 289.41 Mn
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 124.00 Mn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 14.48 Mn
10 Tonix Pharmaceuticals Holding 142.07 Mn 142.07 Mn 5.30 Mn 5,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 5,000.00
Dec 31, 2025 5,000.00
Sep 30, 2025 1.30 Mn
Jun 30, 2025 931,000.00
Mar 31, 2025 900,000.00
Dec 31, 2024 951,000.00
Sep 30, 2024 951,000.00
Jun 30, 2024 961,000.00
Mar 31, 2024 960,000.00
Dec 31, 2023 1.13 Mn
Sep 30, 2023 1.05 Mn
Jun 30, 2023 292,000.00
Mar 31, 2023 385,000.00
Dec 31, 2022 264,000.00
Sep 30, 2022 360,000.00
Jun 30, 2022 379,000.00
Mar 31, 2022 379,000.00
Dec 31, 2021 379,000.00
Sep 30, 2021 240,000.00
Jun 30, 2021 240,000.00